University of Sarajevo Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2015
NCT02249429
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Anbiome Labs LLC | University Clinical Center, Sarajevo | University of Sarajevo | Universiyt of Sarajevo Faculty of Pharmacy

Active Ingredients

Drugs in Phase 4 Trials (3)

hyperici extractum oleosum (1 trial)

shepherd's purse extractum oleosum (1 trial)

tea (1 trial)

Drugs in Phase 3 Trials (1)

platelet rich fibrin (1 trial)

Drugs in Phase 2 Trials (1)

pqr309 (1 trial)

Drugs in Phase 1 Trials (2)

gliclazide (1 trial)

omeprazole (prilosec) (1 trial)

Drugs in Other Trials (2)

amikacin (Amikin) (1 trial)

cls02021 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Diabetes Mellitus, Type 2 (Phase 1)

Inflammation (Phase 4)

Lymphoma (Phase 2)

Vaginitis (Phase 4)

Vaginosis, Bacterial (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 9